Lilly could pay Innovent Biologics up to $9 billion in a new alliance. Elsewhere, Roche tried to assuage investor concerns about its new multiple sclerosis drug and Roivant shares surged.
Lilly could pay Innovent Biologics up to $9 billion in a new alliance. Elsewhere, Roche tried to assuage investor concerns about its new multiple sclerosis drug and Roivant shares surged.
![Solana [SOL] Records New Yearly High Following 13% daily surge](https://lbnntv.com/wp-content/uploads/2023/11/Solana-SOL-Records-New-Yearly-High-Following-13-daily-surge-120x86.png)
